Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
ApartmentLove (C.APLV) Announces Agreement with Yardi (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News TRYP Therapeutics Inc C.TRYP

Alternate Symbol(s):  TRYPF

Healthcare
Tryp Therapeutics Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on developing psilocybin-related molecules, including TRP-8803, for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. The Company’s lead development program, Psilocybin-For-Neuropsychiatric Disorders (PFN) program, is designed to treat neuropsychiatric... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:TRYP)

Tryp Therapeutics Announces Jason Carroll as New Chief Executive Officer

Accesswire August 3, 2023

With Great Sadness Tryp Announces the Passing of David Tousley, Director

Accesswire August 2, 2023

Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital

Accesswire July 13, 2023

Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital

Accesswire May 24, 2023

Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Secured Convertible Debentures for Gross Proceeds of AUD$2,400,000

Accesswire April 27, 2023

Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000

Accesswire April 12, 2023

Tryp Therapeutics Completes Psychotherapy Training for Planned Phase 2a Clinical Trial at Massachusetts General Hospital

Accesswire April 4, 2023

Tryp Therapeutics Announces Interim Results for Its Phase II Clinical Trial for the Treatment of Binge Eating Disorder With Psilocybin-Assisted Psychotherapy

Accesswire January 5, 2023

Tryp Therapeutics and Massachusetts General Hospital Sign Letter of Intent for Clinical Study Investigating the Use of Psilocybin-Assisted Psychotherapy for the Treatment of Patients Suffering From Irritable Bowel Syndrome (IBS)

Accesswire January 3, 2023
View More News ››

Opinion & Analysis (CSE:TRYP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:TRYP)

Tryp Therapeutics Receives Confirmation From FDA To Proceed

KELOWNA, BC / ACCESSWIRE / July 13, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company...
Betteryear2 - July 13, 2023

Making money else where!

Sold off half to free up cash not doing any thing in all most 2 years.
Blackpenny - September 6, 2022

Well, I'm impressed

Somebody has a working brain. Changed the financing - now no warrants + a fat premium to "market" makes TRYP look super...
FastFF - February 28, 2022

Lovely - free warrant for the VC

And he just fired the management team. Chart looks like a ski slope.....all downhill
FastFF - February 4, 2022

Halt trading

  Tryp Therapeutics halted at open   2022-02-04 08:36 ET - Halt Trading   Tryp Therapeutics Inc. has been...
lithiums - February 4, 2022

🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣

<< View Post To Watch Video >>
JayDestura - November 18, 2021
View more Bullboard ››

Zoomd Technologies Ltd

Zoomd Technologies Ltd

Zoomd Technologies Ltd. (ZOMD) offers a mobile application user-acquisition platform, integrated with many global digital ...
View More »